Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

KROSKROS
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in KEROS THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 177,846 shares of KROS (KEROS THERAPEUTICS INC), worth $1.9M as of 2026-Q2. The position was decreased (-20.8% shares). KROS represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$1.9M

Current Shares

177,846

Total Value Change

-$6.6M

Total Shares Change

-357,738

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
177,846
-20.8%
$1.9M0.0%$10.70
0
2026-Q1
Decreased
224,479
-62.0%
$2.5M0.0%$13.40
0
2025-Q4
Decreased
590,517
-55.5%
$12M0.0%$20.27
0
2025-Q3
Increased
1.3M
+50.0%
$21M0.0%$15.95
39
2025-Q2
Increased
883,560
+19.3%
$11.8M0.0%$13.49
33
2025-Q1
Increased
740,606
+38.3%
$7.5M0.0%$10.79
36
2024-Q4
New
535,584
-
$8.5M0.0%$15.64
38

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used